Inspire Advisors, LLC

Position in EXEL — Exelixis, Inc.

CIK 1810558 Meridian, ID

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$890,691

+$158,859 QoQ

Shares Held

16,370

-4.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#350

of 751 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Inspire Advisors, LLC holds $5,818,365 across 11 Biotechnology names. EXEL ranks #3 (15.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	16,711	$1,894,358
2	CRSP	CRISPR Therapeutics AG	19,880	$1,084,255
3	EXEL	Exelixis, Inc. This page	16,370	$890,691
4	TGTX	Tg Therapeutics, Inc.	8,271	$454,408
5	KRYS	Krystal Biotech, Inc.	958	$356,059
6	BBIO	BridgeBio Pharma, Inc.	3,788	$282,130
7	ARWR	Arrowhead Pharmaceuticals, Inc.	3,408	$277,786
8	STOK	Stoke Therapeutics, Inc.	8,423	$275,600

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$890,691	16,370	-4.1%	Shares	Defined	2026-08-13
2026-03-31	$731,832	17,063	-14.7%	Shares	Defined	2026-05-15
2025-12-31	$877,169	20,013	+33.2%	Shares	Sole	2026-02-13
2025-09-30	$620,491	15,024	-8.9%	Shares	Sole	2025-10-29
2025-06-30	$726,879	16,490	-13.1%	Shares	Sole	2025-08-11
2025-03-31	$700,963	18,986	+0.9%	Shares	Sole	2025-05-07
2024-12-31	$626,439	18,812	-25.4%	Shares	Sole	2025-02-07
2024-09-30	$654,121	25,207	+24.9%	Shares	Sole	2024-10-17
2024-06-30	$453,534	20,184	-26.7%	Shares	Sole	2024-08-08
2023-09-30	$601,814	27,543	+119652.2%	Shares	Sole	2023-10-26
2020-12-31	$461	23	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.